Professor Jeremy Chapman Named Editor-in-Chief of Transplantation
Article ID: 617713
Released: 9-May-2014 1:00 PM EDT
Source Newsroom: Wolters Kluwer Health: Lippincott Williams and Wilkins
Newswise — New York, NY -- (May 9, 2014) – Wolters Kluwer Health is pleased to announce that Jeremy R. Chapman, MD, will assume the role of Editor-in-Chief for Transplantation, the official Journal of The Transplantation Society (TTS). The January 1, 2015, issue of Transplantation will be the first under the new editorial team. Prof Chapman is Clinical Director of Medicine and Cancer at Westmead Hospital, NSW, Australia. He currently serves as Editor of Transplantation Reviews and as a Regional Associate Editor for Transplantation and is a Past President of TTS.
The new appointment represents a change in Transplantation, replacing the team of Co-Editors who have directed the journal in recent years. Joining Prof Chapman will be Carla C. Baan, PhD, of Erasmus Medical Center in the role of Basic Sciences Editor; Jonathan S Bromberg, MD, PhD, of University of Maryland Medical School as Clinical Sciences Editor; and Stefan Tullius MD, PhD, of Harvard Medical School as Special Features Editor.
"The Transplantation Society has assembled a most outstanding group of Editors to continue in its mission of leading science and education for the international community," comments Francis L. Delmonico, MD, current President of TTS. "Transplantation is a must-have subscription to acquire the knowledge of scientific and clinical data, perspectives and information to be a successful professional in this field."
Prof Chapman and the new editorial team will assume responsibility for new submissions as of July 1, 2014. Manuscript submission, review, and tracking for the journal will also be substantially revised and streamlined using WKH's Editorial Manager system.
Transplantation is a global journal covering the most important advances in the field of transplantation, including cell therapy and islet transplantation, clinical and experimental transplantation, immunobiology, genomics, and xenotransplantation. Published 24 times a year, it is the most-cited journal in the field of transplantation. In addition to the print journal, subscribers and TTS members can digitally access each issue using both the journal website, www.transplantjournal.com; and the excellent Transplantation for the iPad app.
Prof Chapman looks forward to a redesign of Transplantation, to bring innovation to the content and the media used to present it. "The journal will be an essential read for everyone working in the field of transplantation each fortnight," he comments. "We have many more plans, which we will reveal as we move into 2015—so keep up with the journal to stay in touch."
Outgoing Co-Editor Manikkam Suthanthiran, MD, comments, "I have every confidence that the journal's integrity and objectivity will continue to flourish under the inspired leadership of Professor Chapman and his capable team." Co-Editor Kathryn J. Wood, PhD, adds, "We wish Professor Chapman and the new Editorial Team every success as they continue to develop Transplantation and further enhance its reputation as the most frequently cited journal in the field."
About TransplantationTransplantation has for over 40 years been the trusted source for extensive and timely coverage of the most important advances in transplantation. The Editors and Editorial Board of Transplantation are an international group of research and clinical leaders that includes many pioneers of the field, representing a diverse range of areas of expertise. This capable editorial team provides thoughtful and thorough peer review, and delivers rapid, careful and insightful editorial evaluation of all manuscripts submitted to the journal. The official Journal of The Transplantation Society, Transplantation is published twice monthly and is the most cited and influential journal in the field, with more than 25,000 citations a year.
About Wolters Kluwer HealthWolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health’s customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2012 annual revenues of €3.6 billion ($4.6 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Follow our official Twitter handle: @WKHealth.